Please login to the form below

Not currently logged in
Email:
Password:

Eisai expands in the Middle East with new Dubai office

Japanese pharma company opens regional representative base in Dubai Healthcare City

Eisai EMEA Dubai

Japanese pharma company Eisai has expanded its reach into the Middle East, setting up a new regional representative office in Dubai.

Based in the emirate's Dubai Healthcare City complex, the Eisai EMEA (Europe, Middle East and Africa) Dubai branch office will be led by EMEA regional director Ayman ElDeeb.

“Eisai's entry into the Middle East and Africa region enforces our wider plan of increasing access to medicines based on a strategy of affordability, availability, adoption and architecture,” he said.

“This expansion is an opportunity to make our currently marketed and pipeline products available, as well as to explore in-licensing of products which may match specific patient needs in the region.”

Dubai Healthcare City is home to two hospitals, over 90 outpatient medical centres and diagnostic laboratories with over 2,500 licensed professionals.

From this base Eisai plans to build on the 2009 launch of its peripheral neuropathy treatment Methycobal (mecobalamin) in Saudi Arabia, the United Arab Emirates and other Middle East countries by bringing some of its oncology and neurology products to the region.

These will include the pharma firm's new metastatic breast cancer treatment Halaven (eribulin) as well as a novel agent for the treatment of epilepsy.

Eisai first started doing business in the Middle East in the 1960s, but only started moving away from using local distributors for the region when it opened an office in Bahrain three years ago.

In addition to strengthening its regional presence, the company also hopes to use the new EMEA Dubai office as a base for its entry into certain parts of Africa.

The office also adds to the firm's established EMEA presence, which is centred around its EMEA business headquarters in Hatfield, UK.

Eisai recently expanded the £100m Hatfield facility to take on additional responsibly for operations in the Middle East and Africa, creating a number of new UK jobs.

19th April 2012

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Lifting the fog to help Clinical Labs navigate IVDR 2022
In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests. BD wanted to let their...
Empowering adolescents to manage emotional and mental health issues
1 in 10 UK children suffer with a mental health issue and alarmingly as many as 70% of these don’t receive the proper support they need. That’s why The Anna...
Reframing rare to increase earlier diagnosis of Gaucher Disease
Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its...